Loading...

Loading...

The Good, the Bad and the Ugly of Medicine Procurement, Part III
By Karel Fucikovsky de Grunhof Knap - Wed, 03/29/2023 - 13:00
Karel Fucikovsky presents the good, the bad and the ugly of Mexico’s ‘free’ healthcare and failed medicine procurement program.
https://mexicobusiness.news/tag/pierre-fabre
More Health
Mexican Healthcare: The Good, The Bad and the Ugly II
By Karel Fucikovsky de Grunhof Knap - Wed, 12/14/2022 - 13:00
Mexico needs qualified, well-compensated healthcare professionals. Karel Fucikovsky explains the good, the bad and the ugly of the situation.
The Good, the Bad and the Ugly of Mexico's Health Sector
By Karel Fucikovsky de Grunhof Knap - Fri, 07/22/2022 - 11:00
There continues to be a large healthcare gap between what is expected and promised versus what the population is receiving, writes Karel Fucikovsky.
Caught in the Middle
By Karel Fucikovsky de Grunhof Knap - Tue, 09/21/2021 - 17:53
At the midpoint of the presidential administration, healthcare is stuck in the middle. It’s time to move on, writes Karel Fucikovsky.
Midterm Elections’ Impact on Healthcare
By Miriam Bello - Mon, 06/14/2021 - 15:05
After many controversial reform proposals during AMLO’s administration, the sector sees a calmer future.
Mexico’s Endemic Services Need Pandemic Care
By Karel Fucikovsky de Grunhof Knap - Tue, 03/09/2021 - 09:18
Tourism and its associated services are in intensive care. It’s time to include them in the national vaccination strategy, says Karel Fucikovsky
Pharmaceutical Industry Going Through Intense Therapy
By Mónica López - Tue, 02/16/2021 - 09:40
The pharmaceutical industry is going through intensive therapy, not as a patient but as an ally in supporting the health sector and its users
Pharmaceutical Industry at the Front Line of the Pandemic
By Andrea Villar - Wed, 01/27/2021 - 12:30
The pharmaceutical industry is going through intensive therapy, not as a patient but as an ally in supporting the health sector and its users
A New Way Forward for the Pharmaceutical Industry
By Jan Hogewoning - Thu, 12/03/2020 - 16:48
Sandra Sanchéz-Oldenhage’s call for more customer-centricity as pharmaceutical companies have to adapt to new realities.
Unified Innovation to Explore Nontraditional Pharma Markets
By Miriam Bello - Mon, 11/30/2020 - 12:15
Strengthening its focus on oncology, Pierre Fabre is looking to make Mexico a primary destination for its solutions.